Cutler Group LP Clene Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

A detailed history of Cutler Group LP transactions in Clene Inc. stock. As of the latest transaction made, Cutler Group LP holds 3,900 shares of CLNN stock, worth $16,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,900
Previous 3,900 -0.0%
Holding current value
$16,770
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023
SELL
$0.95 - $1.62 $285 - $486
-300 Reduced 7.14%
3,900 $4,000
Q4 2022

Feb 07, 2023
BUY
$0.92 - $40.2 $2,392 - $104,520
2,600 Added 162.5%
4,200 $4,000
Q3 2022

Oct 25, 2022
BUY
$0.33 - $73.0 $528 - $116,800
1,600 New
1,600 $4,000

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $273M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email